BRITISH JOURNAL OF DERMATOLOGY, cilt.144, sa.6, ss.1121-1126, 2001 (SCI-Expanded)
Background T-cell activation has been implicated in the pathogenesis of psoriasis; adenosine deaminase (ADA) activity has been considered as a marker of T-cell activation. The antithyroid drug propylthiouracil (PTU) has recently been shown to have beneficial effects on psoriatic lesions, probably by acting on the immune system.